Cytoplasmic Nucleolin Expression in Chronic Lymphocytic Leukemia

References (10)

1. Jia W, Yao Z, Zhao J et al. New perspectives of physiological and pathological functions of nucleolin (NCL). Life Sci 186: 1-10, 2017
2. Xu X, Chen Z. Roles of nucleolin, focus on cancer and anticancer therapy. Saudi Med J 37: 1312-1318, 2016
3. Berger CM, Gaume X, Bouvet P. The roles of nucleolin subcellular localization in cancer. Biochimie 113: 78-85, 2015
4. Wise JF, Berkova Z, Mathur R et al. Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex. Blood 121: 4729-4739, 2013
5. Allinne J, Pichugin A, Iarovaia O et al. Perinucleolar relocalization and nucleolin as crucial events in the transcriptional activation of key genes in mantle cell lymphoma. Blood 123: 2044-2053, 2014
6. Jain N, Zhu H, Khashab T et al. Targeting nucleolin for better survival in diffuse large B-cell lymphoma. Leukemia 32: 663- 674, 2018
7. Marcel V, Catez F, Berger CM et al. Expression profiling of ribosome biogenesis factors reveals nucleolin as a novel potential marker to predict outcome in AML patients. PLoS One 12(1): e0170160, 2017
8. Shen N, Yan F, Pang J et al. A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis. Oncotarget 5(14): 5494-509, 2014
9. Gattoni-Celli S, Buckner CL, Lazarchick J et al. Overexpression of nucleolin in engrafted acute myelogenous leukemia cells. Am J Hematol 84: 535-538, 2009
10. Otake Y, Soundararajan S, Sengupta TK et al. Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood 109: 3069-3075, 2007.